Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Withdrawn 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 2CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Kidney Neoplasms 1Glioblastoma 1Coronary Artery Disease 1Clear-cell metastatic renal cell carcinoma 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Molecular Imaging × Clear all
NCT01957332 2024-11-20

IMPACT-MBC

University Medical Center Groningen

Phase NA Active not recruiting
217 enrolled
Breast

Breast Neoplasms

NCT02249520 2024-08-21

Calibration of MR and PET-MR Imaging Protocols at RIC

Cedars-Sinai Medical Center

Phase NA Withdrawn

Coronary Artery Disease, Neoplasms

NCT01622764 2024-05-06

89Zr-RO5323441 PET Imaging in Glioblastoma

University Medical Center Groningen

Phase 2 Withdrawn
CNS

Glioblastoma

NCT02813226 2021-12-21

MISTER

Ontario Clinical Oncology Group (OCOG)

Phase NA Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT02228954 2021-12-07

IMPACT-RCC

Radboud University Medical Center

Completed
40 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡